scispace - formally typeset
R

Rachel Legeron

Researcher at Université Bordeaux Segalen

Publications -  8
Citations -  142

Rachel Legeron is an academic researcher from Université Bordeaux Segalen. The author has contributed to research in topics: Free fraction & Prospective cohort study. The author has an hindex of 5, co-authored 8 publications receiving 99 citations.

Papers
More filters
Journal ArticleDOI

Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study

TL;DR: In this article, the authors assessed whether augmented renal clearance (ARC) impacts negatively on antibiotic concentrations and clinical outcomes in patients treated by high-dose β-lactams administered continuously, and the performance of CLCr was assessed by a ROC curve, and multivariable logistic regression was performed to determine risk factors for subexposure and therapeutic failure.
Journal ArticleDOI

Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.

TL;DR: Obese patients were more likely than nonobese patients to experience piperacillin underdosing when facing high minimal inhibitory concentration pathogens, and p Piperacillin drug monitoring might be necessary in the sickest patients who are at the highest risk of unpredictable plasma concentration exposing them to overdose, toxicity, underdoses, and treatment failure.
Journal Article

A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC–MS/MS in human plasma comparing two internal standard calibration approaches B Analytical technologies in the biomedical and life sciences

TL;DR: A reliable and cost-effective LC-MS/MS method to quantify total plasmatic fraction of bevacizumab in human plasma and proposed a generic methodology easily transposable to quantify all IgG1 subclass very useful for clinical pharmacokinetics studies.